Daulouède JP - Search Results

1

French field experience with buprenorphine.

Auriacombe M, Fatséas M, Dubernet J, Daulouède JP, Tignol J. Auriacombe M, et al. Among authors: daulouede jp. Am J Addict. 2004;13 Suppl 1:S17-28. doi: 10.1080/10550490490440780. Am J Addict. 2004. PMID: 15204673

2

[Substitution therapy in drug addictions].

Auriacombe M, Fatseas M, Franques-Rénéric P, Daulouède JP, Tignol J. Auriacombe M, et al. Among authors: daulouede jp. Rev Prat. 2003 Jun 15;53(12):1327-34. Rev Prat. 2003. PMID: 12920942 Review. French.

3

[Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature].

Loustauneau A, Auriacombe M, Daulouede JP, Tignol J. Loustauneau A, et al. Among authors: daulouede jp. Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S31-6. Ann Med Interne (Paris). 2002. PMID: 12518080 Review. French.

4

Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002.

Lavie E, Fatséas M, Daulouède JP, Denis C, Dubernet J, Cattan L, Auriacombe M. Lavie E, et al. Among authors: daulouede jp. Patient Prefer Adherence. 2008 Feb 2;2:369-78. doi: 10.2147/ppa.s4136. Patient Prefer Adherence. 2008. PMID: 19920984 Free PMC article.

5

Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy.

Fatseas M, Denis C, Serre F, Dubernet J, Daulouède JP, Auriacombe M. Fatseas M, et al. Among authors: daulouede jp. AIDS Behav. 2012 Oct;16(7):2082-90. doi: 10.1007/s10461-011-0054-4. AIDS Behav. 2012. PMID: 21983799

6

A naturalistic follow-up study of French-speaking opiate-maintained heroin-addicted patients: effect on biopsychosocial status.

Auriacombe M, Grabot D, Daulouède JP, Vergnolle JP, O'Brien C, Tignol J. Auriacombe M, et al. Among authors: daulouede jp. J Subst Abuse Treat. 1994 Nov-Dec;11(6):565-8. doi: 10.1016/0740-5472(94)90008-6. J Subst Abuse Treat. 1994. PMID: 7884840

7

[Descriptive studies of the use of the Addiction Severity Index in France].

Martin C, Grabot D, Auriacombe M, Brisseau S, Daulouède JP, Tignol J. Martin C, et al. Among authors: daulouede jp. Encephale. 1996 Sep-Oct;22(5):359-63. Encephale. 1996. PMID: 9035992 French.

8

[Quantitative evaluation of sharing practices of materials at risk for infectious virus contamination by intravenous opiate users seeking treatment--application of the RAB(Risk for AIDS Behavior) self-administered questionnaire].

Bertorelle V, Auriacombe M, Grabot D, Franques P, Martin C, Daulouede JP, Tignol J. Bertorelle V, et al. Among authors: daulouede jp. Encephale. 2000 May-Jun;26(3):3-7. Encephale. 2000. PMID: 10951900 French.

9

Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.

Dematteis M, Auriacombe M, D'Agnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, Daulouede JP, Leonardi C, Maremmani I, Torrens M, Walcher S, Soyka M. Dematteis M, et al. Among authors: daulouede jp. Expert Opin Pharmacother. 2017 Dec;18(18):1987-1999. doi: 10.1080/14656566.2017.1409722. Epub 2017 Dec 3. Expert Opin Pharmacother. 2017. PMID: 29183228 Review.

10

[Evaluation of the use of psychotropic drugs from urine samples from subjects attending for the first time a clinic specializing in opium addiction].

Bonnand B, Auriacombe M, Franques P, Bertorelle V, Afflelou S, Daulouède JP, Combourieu I, Tignol J. Bonnand B, et al. Among authors: daulouede jp. Presse Med. 1999 Apr 3;28(13):679-82. Presse Med. 1999. PMID: 10228474 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page